Lavish Spending at MD Anderson

The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.

Written byKate Yandell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, FAUNGGAn investigation by The Cancer Letter reveals that the University of Texas MD Anderson Cancer Center may have spent at least $1.5 million dollars on a project to remodel a suite of office and meeting spaces for Lynda Chin, chair of MD Anderson’s department of genomic medicine and scientific director of the new Institute for Applied Cancer Science (IACS). Chin is also the wife of Ronald DePinho, MD Anderson’s president.

MD Anderson disputes the report, saying that the office renovations cost $547,434 and that the higher figure of $1.5 million included lab equipment such as fume hoods and ventilation.

The Cancer Letter based its assertions on 680 pages of internal documents it obtained through the Texas Public Information Act. The purchases included a total of $210,000 worth of glass walls and doors to “provide a feeling of transparency,” according to the documents. It also includes two settees worth $7,754 and $6,961, two $5,000 credenzas, and other expensive furniture. The money came from MD Anderson’s capital project funds, which are “derived from investment income, philanthropy, and patient revenue,” according to an MD Anderson statement sent to The Cancer Letter.

The renovations were supposed to make the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies